SG131765A1 - New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number: SG131765A1
Authority: SG; Singapore
Prior art keywords: preparation; new; pharmaceutical compositions; compositions containing; carbazole compounds
Prior art date: 2002-10-16

Application number

SG200306491-2A

Other languages

English (en)

Inventor

Michelle Prudhomme

Bernadette Hugon

Fabrice Anizon

John Hickman

Alain Pierre

Roy Golsteyn

Pierre Renard

Bruno Pfeiffer

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-16

Filing date

2003-10-16

Publication date

2007-05-28

2003-10-16 Application filed by Servier Lab filed Critical Servier Lab

2007-05-28 Publication of SG131765A1 publication Critical patent/SG131765A1/en

Links

125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Obesity (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)

SG200306491-2A 2002-10-16 2003-10-16 New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them SG131765A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0212847A FR2845996A1 (fr)	2002-10-16	2002-10-16	Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
SG131765A1 true SG131765A1 (en)	2007-05-28

Family

ID=29725330

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG200306491-2A SG131765A1 (en)	2002-10-16	2003-10-16	New [3,4-a:3,4-c]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (25)

Country	Link
US (1)	US7151108B2 (de)
EP (1)	EP1411057B1 (de)
JP (1)	JP2004277404A (de)
KR (1)	KR100502250B1 (de)
CN (1)	CN1241925C (de)
AR (1)	AR041618A1 (de)
AT (1)	ATE294181T1 (de)
AU (1)	AU2003254746A1 (de)
BR (1)	BR0304575A (de)
CA (1)	CA2443585A1 (de)
DE (1)	DE60300571T2 (de)
DK (1)	DK1411057T3 (de)
EA (1)	EA007250B1 (de)
ES (1)	ES2240927T3 (de)
FR (1)	FR2845996A1 (de)
MA (1)	MA27007A1 (de)
MX (1)	MXPA03009362A (de)
MY (1)	MY134620A (de)
NO (1)	NO20034614L (de)
NZ (1)	NZ528902A (de)
PL (1)	PL362885A1 (de)
PT (1)	PT1411057E (de)
SG (1)	SG131765A1 (de)
SI (1)	SI1411057T1 (de)
ZA (1)	ZA200308053B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI499414B (zh)	2006-09-29	2015-09-11	Lexicon Pharmaceuticals Inc	鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ２）的抑制物與其應用方法
US7846945B2 (en)	2007-03-08	2010-12-07	Lexicon Pharmaceuticals, Inc.	Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
US9758505B2 (en)	2014-02-12	2017-09-12	Iteos Therapeutics	3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use
CN103804278B (zh) *	2014-02-19	2016-04-13	西北大学	一种天然产物2-甲基-3-甲氧基-咔唑-1,4-苯醌的制备方法
TN2016000501A1 (en)	2014-05-15	2018-04-04	Iteos Therapeutics	Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors.
US9873690B2 (en)	2015-03-17	2018-01-23	Pfizer Inc	3-indol substituted derivatives, pharmaceutical compositions and methods for use
JP2016216446A (ja) *	2015-05-14	2016-12-22	ファイザー・インク	ピロリジン−２，５−ジオン誘導体の多形形態、医薬組成物、およびｉｄｏ１阻害薬としての使用方法
US10544095B2 (en)	2015-08-10	2020-01-28	Pfizer Inc.	3-indol substituted derivatives, pharmaceutical compositions and methods for use
CN106832175B (zh) *	2017-02-17	2019-10-18	华南理工大学	一种基于咔唑衍生物的双羟基荧光扩链剂及其制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3010675B2 (ja) *	1989-03-23	2000-02-21	萬有製薬株式会社	抗腫瘍性物質ｂｅ―１３７９３ｃ

2002
- 2002-10-16 FR FR0212847A patent/FR2845996A1/fr not_active Withdrawn
2003
- 2003-09-19 MY MYPI20033597A patent/MY134620A/en unknown
- 2003-09-26 MA MA27327A patent/MA27007A1/fr unknown
- 2003-09-26 US US10/672,418 patent/US7151108B2/en not_active Expired - Fee Related
- 2003-10-13 MX MXPA03009362A patent/MXPA03009362A/es active IP Right Grant
- 2003-10-14 AT AT03292545T patent/ATE294181T1/de not_active IP Right Cessation
- 2003-10-14 DK DK03292545T patent/DK1411057T3/da active
- 2003-10-14 ES ES03292545T patent/ES2240927T3/es not_active Expired - Lifetime
- 2003-10-14 DE DE60300571T patent/DE60300571T2/de not_active Expired - Fee Related
- 2003-10-14 SI SI200330032T patent/SI1411057T1/xx unknown
- 2003-10-14 PT PT03292545T patent/PT1411057E/pt unknown
- 2003-10-14 EP EP03292545A patent/EP1411057B1/de not_active Expired - Lifetime
- 2003-10-15 PL PL03362885A patent/PL362885A1/xx not_active Application Discontinuation
- 2003-10-15 AR ARP030103744A patent/AR041618A1/es unknown
- 2003-10-15 EA EA200301020A patent/EA007250B1/ru unknown
- 2003-10-15 NO NO20034614A patent/NO20034614L/no not_active Application Discontinuation
- 2003-10-15 NZ NZ528902A patent/NZ528902A/en unknown
- 2003-10-15 BR BR0304575-7A patent/BR0304575A/pt not_active IP Right Cessation
- 2003-10-15 KR KR10-2003-0071768A patent/KR100502250B1/ko not_active Expired - Fee Related
- 2003-10-15 CA CA002443585A patent/CA2443585A1/fr not_active Abandoned
- 2003-10-16 JP JP2003355815A patent/JP2004277404A/ja active Pending
- 2003-10-16 SG SG200306491-2A patent/SG131765A1/en unknown
- 2003-10-16 ZA ZA200308053A patent/ZA200308053B/xx unknown
- 2003-10-16 AU AU2003254746A patent/AU2003254746A1/en not_active Abandoned
- 2003-10-16 CN CNB200310100563XA patent/CN1241925C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EA200301020A1 (ru)	2004-04-29
CN1496989A (zh)	2004-05-19
MXPA03009362A (es)	2004-04-28
EP1411057B1 (de)	2005-04-27
AR041618A1 (es)	2005-05-26
DK1411057T3 (da)	2005-08-29
ATE294181T1 (de)	2005-05-15
NZ528902A (en)	2004-09-24
ES2240927T3 (es)	2005-10-16
DE60300571T2 (de)	2006-02-23
BR0304575A (pt)	2004-07-20
FR2845996A1 (fr)	2004-04-23
SI1411057T1 (de)	2005-08-31
NO20034614D0 (no)	2003-10-15
EP1411057A1 (de)	2004-04-21
MY134620A (en)	2007-12-31
CA2443585A1 (fr)	2004-04-16
JP2004277404A (ja)	2004-10-07
AU2003254746A1 (en)	2004-05-06
KR20040034472A (ko)	2004-04-28
KR100502250B1 (ko)	2005-07-20
US20040077672A1 (en)	2004-04-22
DE60300571D1 (de)	2005-06-02
NO20034614L (no)	2004-04-19
CN1241925C (zh)	2006-02-15
PT1411057E (pt)	2005-08-31
HK1063321A1 (en)	2004-12-24
MA27007A1 (fr)	2004-12-20
ZA200308053B (en)	2004-07-08
US7151108B2 (en)	2006-12-19
PL362885A1 (en)	2004-04-19
EA007250B1 (ru)	2006-08-25

Similar Documents

Publication	Publication Date	Title
HUP0002843A3 (en)	2001-07-30	New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
AU2003239302A1 (en)	2003-09-02	Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
HUP0203136A3 (en)	2003-03-28	Piperazine compounds, process for their preparation, pharmaceutical compositions containing them and their use
HUP0301187A3 (en)	2010-03-29	Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0400208A3 (en)	2008-10-28	N-formyl hydroxylamine compounds, process for their preparation and pharmaceutical compositions containing them
HUP0102622A3 (en)	2002-12-28	Biphenyl derivatives, process for producing them and pharmaceutical compositions containing them
PL359373A1 (en)	2004-08-23	New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them
HUP0100489A3 (en)	2002-10-28	New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0203976A3 (en)	2004-08-30	Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
HUP0104272A3 (en)	2004-01-28	New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en)	2003-10-13	Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
ZA200308053B (en)	2004-07-08	[3,4-A:3,4-C]carbazole compounds, a process for their preparation and pharmaceutical compositions containing them.
SG109010A1 (en)	2005-02-28	New heterocyclic oxime compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en)	2011-07-28	Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
HUP0202379A3 (en)	2003-04-28	New compounds, process for producing them and pharmaceutical compositions containing them
IL147069A0 (en)	2002-08-14	Novel benzene derivatives, a process for their preparation and pharmaceutical compositions containing them
HU0105328D0 (en)	2002-02-28	Novel bicyclic amino-pirazinone compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0004573A3 (en)	2002-06-28	New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200202030B (en)	2002-10-03	Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
EG24369A (en)	2009-03-15	New isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0201024A3 (en)	2003-12-29	Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them
AU2002300093A1 (en)	2003-06-12	New benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
HU9803017D0 (en)	1999-02-01	New heterocyclic compounds, a process for their preparation and pharmaceutical compositions containing them
SG110170A1 (en)	2005-04-28	New benzoindoline compounds, a process for their preparation and pharmaceutical compositions containing them
HUP0004543A3 (en)	2001-11-28	Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them